BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38020751)

  • 1. Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy-Results of a Prospective Single-Center Trial.
    Benning L; Morath C; Fink A; Rudek M; Speer C; Kälble F; Nusshag C; Beimler J; Schwab C; Waldherr R; Zeier M; Süsal C; Tran TH
    Transpl Int; 2023; 36():11899. PubMed ID: 38020751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies.
    Halloran PF; Reeve J; Madill-Thomsen KS; Demko Z; Prewett A; Billings P;
    J Am Soc Nephrol; 2022 Feb; 33(2):387-400. PubMed ID: 35058354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a donor-derived cell-free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection.
    Steggerda JA; Pizzo H; Garrison J; Zhang X; Haas M; Kim IK; Jordan SC; Puliyanda DP
    Pediatr Transplant; 2022 Jun; 26(4):e14258. PubMed ID: 35340104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients.
    Huang E; Sethi S; Peng A; Najjar R; Mirocha J; Haas M; Vo A; Jordan SC
    Am J Transplant; 2019 Jun; 19(6):1663-1670. PubMed ID: 30725531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Response of Donor-Derived Cell-Free DNA Following Treatment of Acute Rejection in Kidney Allografts.
    Wolf-Doty TK; Mannon RB; Poggio ED; Hinojosa RJ; Hiller D; Bromberg JS; Brennan DC
    Kidney360; 2021 Apr; 2(4):729-736. PubMed ID: 35373051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation.
    Obrișcă B; Butiu M; Sibulesky L; Bakthavatsalam R; Smith KD; Gimferrer I; Warner P; Ismail G; Leca N
    Sci Rep; 2022 Sep; 12(1):15061. PubMed ID: 36064740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants.
    Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC
    Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study.
    Zhang H; Zheng C; Li X; Fu Q; Li J; Su Q; Zeng L; Liu Z; Wang J; Huang H; Xu B; Ye M; Liu L; Wang C
    Front Immunol; 2020; 11():342. PubMed ID: 32184785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study.
    Khush KK; Patel J; Pinney S; Kao A; Alharethi R; DePasquale E; Ewald G; Berman P; Kanwar M; Hiller D; Yee JP; Woodward RN; Hall S; Kobashigawa J
    Am J Transplant; 2019 Oct; 19(10):2889-2899. PubMed ID: 30835940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between donor-derived cell-free DNA and tissue-based rejection-related transcripts in heart transplantation.
    Lee DH; Usmani A; Wu R; Wicks T; Noh CY; Burke R; Ravichandran V; Wolf-Doty T; Dumitru I; Oliveira GH; Berman P; Mackie B
    J Heart Lung Transplant; 2024 Jul; 43(7):1118-1125. PubMed ID: 38373559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study.
    Oellerich M; Shipkova M; Asendorf T; Walson PD; Schauerte V; Mettenmeyer N; Kabakchiev M; Hasche G; Gröne HJ; Friede T; Wieland E; Schwenger V; Schütz E; Beck J
    Am J Transplant; 2019 Nov; 19(11):3087-3099. PubMed ID: 31062511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury.
    Stites E; Kumar D; Olaitan O; John Swanson S; Leca N; Weir M; Bromberg J; Melancon J; Agha I; Fattah H; Alhamad T; Qazi Y; Wiseman A; Gupta G
    Am J Transplant; 2020 Sep; 20(9):2491-2498. PubMed ID: 32056331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of donor-derived cell-free DNA to predict antibody-mediated rejection in donor-specific antibody-positive renal allograft recipients.
    Mayer KA; Doberer K; Tillgren A; Viard T; Haindl S; Krivanec S; Reindl-Schwaighofer R; Eder M; Eskandary F; Casas S; Wahrmann M; Regele H; Böhmig GA
    Transpl Int; 2021 Sep; 34(9):1689-1702. PubMed ID: 34448270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Both Plasma and Urine Donor-Derived Cell-Free DNA to Identify Various Renal Allograft Injuries.
    Chen XT; Qiu J; Wu ZX; Zhang H; Chen T; Yang SC; Zhao GD; He Y; Shen X; Luo JQ; Huang Y; Wang CX; Chen LZ; Wu CL; Huang G
    Clin Chem; 2022 Jun; 68(6):814-825. PubMed ID: 35587713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol-based donor-derived cell-free DNA surveillance in kidney transplant recipients: A single-center experience.
    Nissaisorakarn P; Patel H; Amtul A; Pavlakis M
    Clin Nephrol; 2022 Aug; 98(2):65-74. PubMed ID: 35445660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of Donor-derived Cell-free DNA Into Clinical Practice for Renal Allograft Management.
    Qazi Y; Patel A; Fajardo M; McCormick S; Fehringer G; Ahmed E; Malhotra M; Demko ZP; Billings PR; Tabriziani H; Gauthier P
    Transplant Proc; 2021 Dec; 53(10):2866-2872. PubMed ID: 34774309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-derived cell-free DNA and renal allograft rejection in surveillance biopsies and indication biopsies.
    Chang JH; Alvarado Verduzco H; Toma K; Sritharan S; Mohan S; Husain SA
    Clin Transplant; 2022 Apr; 36(4):e14561. PubMed ID: 34913202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Donor Derived Cell Free DNA (dd-cfDNA) at Surveillance and at Clinical Suspicion of Acute Rejection in Renal Transplantation.
    Mantios E; Filiopoulos V; Constantoulakis P; Liapis G; Vittoraki A; Casas S; Marinaki S; Boletis JN
    Transpl Int; 2023; 36():11507. PubMed ID: 37901296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of donor-derived cell-free DNA between single versus double lung transplant recipients.
    Keller MB; Meda R; Fu S; Yu K; Jang MK; Charya A; Berry GJ; Marboe CC; Kong H; Luikart H; Ponor IL; Shah PD; Khush KK; Nathan SD; Agbor-Enoh S
    Am J Transplant; 2022 Oct; 22(10):2451-2457. PubMed ID: 35322546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observed elevated donor-derived cell free DNA in orthotopic heart transplant recipients without clinical evidence of rejection.
    Afzal A; Alam A; van Zyl JS; Zafar H; Felius J; Hall SA; Carey SA
    Clin Transplant; 2022 Mar; 36(3):e14549. PubMed ID: 34863042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.